Showing results (2791-2800 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 17, 2010
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell linesMartin Schmidt-Hieber, Robert Dabrowski, Andreas Weimann, et al.
Investigational New Drugs|May 22, 2010
Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetanMoon Jin Kim, Gyeong-Won Lee, Jong Woo Seo, et al.
Investigational New Drugs|June 26, 2010
Anti-tumour effects of xanthone derivatives and the possible mechanisms of actionQuan-Guan Su, Yan Liu, Yu-Chen Cai, et al.
Investigational New Drugs|July 14, 2010
Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin CMarina F Vita, Nivedita Nagachar, Dimitrios Avramidis, et al.
Investigational New Drugs|July 30, 2010
The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis modelJieun Yu, Hyuk-Joon Lee, Keun Hur, et al.
Investigational New Drugs|July 13, 2010
Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomasRamón Salazar, Ruth Plummer, Ana Oaknin, et al.
Investigational New Drugs|July 13, 2010
Reactivation of tuberculosis during temsirolimus therapyRomain Coriat, Olivier Mir, Stanislas Ropert, et al.
Investigational New Drugs|July 28, 2010
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumorsRajul K Jain, Donald L Trump, Merrill J Egorin, et al.
Investigational New Drugs|September 15, 2010
A phase I study of continuous infusion cilengitide in patients with solid tumorsPeter H O'Donnell, Samir D Undevia, Walter M Stadler, et al.
Investigational New Drugs|September 15, 2010
Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignanciesLisa A Hammond-Thelin, Melanie B Thomas, Michiko Iwasaki, et al.
Pageof 372